Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Diabetes & Metabolism|November 21, 2017
Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetesT S Bailey, J Pettus, R Roussel, et al.The Biochemical Journal|July 6, 2001
Variation in aspects of cysteine proteinase catalytic mechanism deduced by spectroscopic observation of dithioester intermediates, kinetic analysis and molecular dynamics simulationsJ D Reid, S Hussain, S K Sreedharan, et al.Diabetes, Obesity & Metabolism|July 7, 2016
Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trialT S Bailey, R Takács, F J Tinahones, et al.Diabetes, Obesity & Metabolism|March 19, 2016
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)V R Aroda, T S Bailey, B Cariou, et al.Journal of the Royal Society of Medicine|December 4, 2002
Outpatient clinic: where is the delay?H R H Patel, C N Luxman, T S Bailey, et al.Diabetes, Obesity & Metabolism|June 29, 2016
Basal insulin peglispro versus insulin glargine in insulin-naïve type 2 diabetes: IMAGINE 2 randomized trialM J Davies, D Russell-Jones, J-L Selam, et al.Pageof 2